Previous 10 | Next 10 |
If you are looking to invest in companies that aim to provide disruptive technology to the healthcare sector, there can be plenty of intriguing options. While some of those may lack a solid foundation to build a high-quality business on, 10x Genomics (NASDAQ: TXG) and DermTech ...
Image source: The Motley Fool. 10X Genomics Inc (NASDAQ: TXG) Q3 2021 Earnings Call Nov 3, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: 10X Genomics Inc (TXG) Q3 2021 Earnings Call Transcript
10x Genomics (NASDAQ:TXG): Q3 GAAP EPS of -$0.15 beats by $0.05. Revenue of $125.3M (+74.5% Y/Y) beats by $2.48M. Press Release 10x Genomics is revising its full year 2021 revenue guidance to $490 million to $500 million, representing 64% to 67% growth over full year 2020 revenue. For furth...
10x Genomics Reports Third Quarter 2021 Financial Results Q3 2021 revenue growth of 74% over prior year and 8% over prior quarter PR Newswire PLEASANTON, Calif. , Nov. 3, 2021 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG) today reported financial resu...
10x Genomics Celebrates Opening of Singapore Manufacturing and Commercial Hub Strengthens supply chain continuity with first manufacturing facility outside of the U.S. PR Newswire SINGAPORE , Oct. 25, 2021 /PRNewswire/ -- 10x Genomics (Nasdaq: TXG), a li...
ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. Higher yields as well as uncertainty over inflation, supp...
COVID-19 has radically transformed the valuations of vaccines in the stock market. Novavax has jumped from $4 a share to $164. Moderna has run up from $19 to $304. The vaccine stocks have run up the most because that subsector is still our best hope for defeating COVID-19 once and f...
10x Genomics to Report Third Quarter Financial Results on November 3, 2021 PR Newswire PLEASANTON, Calif. , Oct. 7, 2021 /PRNewswire/ -- 10x Genomics (Nasdaq: TXG) today announced it will report financial results for the third quarter 2021 after market close...
PLEASANTON, Calif., Aug. 31, 2021 (GLOBE NEWSWIRE) -- 10x Genomics, Inc. (Nasdaq: TXG), today announced the company will be participating in the Morgan Stanley 19 th Annual Global Healthcare Conference. 10x Genomics’ management is scheduled to present on Monday, September 1...
BIGZ was launched earlier this year and has since done a lot of nothing in terms of movement. The fund launched at a $20 NAV and last closed at $19.96, a large move with the prior close helped add $0.55 (August 27th). I view BIGZ as a long-term type holding that can provide income...
News, Short Squeeze, Breakout and More Instantly...
2024-07-23 06:00:09 ET Kyle Mikson from Canaccord Genuity issued a price target of $32.00 for TXG on 2024-07-23 05:09:00. The adjusted price target was set to $32.00. At the time of the announcement, TXG was trading at $18.11. The overall price target consensus is at $24...
10x Genomics to Report Second Quarter 2024 Financial Results on August 8, 2024 PR Newswire PLEASANTON, Calif. , July 12, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced that it will report fi...
A look at the top 10 most actives in the United States Kazia Therapeutics Limited (KZIA) rose 248.0% to $0.6682 on volume of 430,252,408 shares Maxeon Solar Technologies Ltd. (MAXN) fell 15.0% to $0.2108 on volume of 237,403,092 shares NVIDIA Corporation (NVDA) rose 2.7% to $134.91 on vol...